Karus Therapeutics presenting at AACR Annual Meeting 2016

Oxford, UK, 29 March 2016– Karus Therapeutics, a leader in the development of innovative medicines for the treatment of cancer, has announced it will be giving a poster presentation at the AACR Annual Meeting in New Orleans, 16-20 April 2016. Stephen Shuttleworth, Karus’s CSO, will present the poster “KA2237 and KA2507: Novel, oral cancer immunotherapeutics targeting […]

Karus Therapeutics presenting at BioTrinity 2016

Oxford, UK, 21 March 2016 – Karus Therapeutics, a leader in the development of innovative medicines for the treatment of cancer, has announced that it will be giving a company presentation at BioTrinity 2016, London, UK, 25-27 April 2016. For more information on Karus’s presentations or for media enquiries, please contact karus@instinctif.com.

Karus Therapeutics presenting at Sachs 9th Annual European Life Science CEO Forum & Exhibition

Oxford, UK, 1 March 2016 – Karus Therapeutics, a leader in the development of innovative medicines for the treatment of cancer, has announced that it will be presenting at Sachs 9th Annual European Life Science CEO Forum & Exhibition, Zurich, Switzerland, 15-16th March 2016. Simon Kerry, Karus’s CEO, will be a panellist on Oncology I […]